Scientists have developed a new way to reprogram human blood cells into stem cells, which could potentially be used to study and treat a wide range of diseases.
The technique, published in the journal Nature, involves taking a small sample of blood and reprogramming the white blood cells into induced pluripotent stem cells (iPSCs). These iPSCs can then be differentiated into any type of cell in the body, making them a valuable tool for studying human development and disease.
"This is a major breakthrough that will open up new avenues for research into human diseases," said lead author Dr. George Daley, director of the Stem Cell Transplantation Program at Boston Children's Hospital. "We can now study diseases in a way that was never possible before, and we can potentially develop new treatments based on our findings."
The researchers used the new technique to study sickle cell anemia, a genetic disorder that affects the red blood cells. They reprogrammed blood cells from patients with sickle cell anemia into iPSCs and then differentiated them into red blood cells. By studying these reprogrammed red blood cells, the researchers were able to identify new genetic mutations that contribute to the disease.
The researchers also used the new technique to study a rare genetic disorder called Diamond-Blackfan anemia, which affects the bone marrow. They reprogrammed blood cells from patients with Diamond-Blackfan anemia into iPSCs and then differentiated them into bone marrow cells. By studying these reprogrammed bone marrow cells, the researchers were able to identify new genes that are involved in the disease.
The researchers believe that the new technique could be used to study a wide range of other diseases, including cancer, heart disease, and diabetes. They are hopeful that the technique will lead to new treatments for these diseases.
"This is a very promising new technology," said Dr. Francis Collins, director of the National Institutes of Health (NIH). "It has the potential to revolutionize the way we study and treat human diseases."
The NIH is providing funding for further research on the new technique.
